Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2010
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267758 Pharmaceutical formulation
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267700 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267667 Telomerase activating compounds and methods of use thereof
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267660 microorganism comprising a heterologous gene encoding a bifunctional Campylobacter jejuni sialytransferase polypeptide and which lacks Neu5Ac aldolase activity and beta galactosidase activity; treating Miller Fisher syndrome
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267627 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
10/21/2010US20100267622 Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267613 Hypoallergenic cereal protein and uses thereof
10/21/2010US20100267129 Chimeric nucleic acids encoding polypeptides comprising domains of tnf family ligands
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266696 Organic Compounds
10/21/2010US20100266672 Vaccines
10/21/2010US20100266668 Manufacturing Dissolvable Dosage Forms
10/21/2010US20100266627 Allelic exchange mutagenesis in map
10/21/2010US20100266625 Meningococcal and Pneumococcal Conjugate Vaccine and Method of Using Same
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266623 Synthetic, self adjuvanting vaccines
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266610 Auto-antibody markers of autoimmune disease
10/21/2010US20100266605 Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
10/21/2010US20100266604 Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266597 Cytokine receptor zcytor17 multimers
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266582 Inhibition of il-17 production
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266578 Treatment and diagnostic methods for hypersensitive disorders
10/21/2010US20100266550 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
10/21/2010US20100266549 Novel probiotics for pet food applications
10/21/2010US20100266541 Methods and agents for modulating an immune response
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266533 Death Domain Containing Receptors
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266496 Anti-CD74 Immunoconjugates and Methods of Use
10/21/2010CA2758921A1 Meningococcal and pneumococcal conjugate vaccine and method of using same
10/21/2010CA2758864A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
10/21/2010CA2758542A1 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010CA2758538A1 Pharmaceutical composition for treating dermatological autoimmune diseases
10/21/2010CA2758449A1 Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp)
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2756759A1 Imidazopyrazines for use as kinase inhibitors
10/20/2010EP2241616A1 Immunity enhancing lactic acid bacteria
10/20/2010EP2241558A1 Oxadiazole derivatives
10/20/2010EP2241317A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
10/20/2010EP2241309A2 Methods for encapsulation of proteins and adjuants in microspheres
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240463A2 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
10/20/2010EP2240440A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
10/20/2010EP2240439A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/20/2010EP2240438A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
10/20/2010EP2240202A2 Allergy vaccine composition for mucosal administration
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240028A1 Organic compounds
10/20/2010EP1811998B1 Triazoles useful as inhibitors of protein kinases
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010EP1091938B1 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
10/20/2010CN1870998B Ccr-2拮抗剂盐 Ccr-2 antagonists salt
10/20/2010CN1509327B CD4+CD25+regulatory T cells from human blood
10/20/2010CN101868251A Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/20/2010CN101868156A Citrulline-containing drink
10/20/2010CN101863930A Certain aminoalkyl glucosaminide phosphate compounds and their use
10/20/2010CN101863878A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
10/20/2010CN101863871A Total glycosides of Rhodiola rosea, medical application and preparation method thereof
10/20/2010CN101863867A Derivatives of flavonoids compounds and preparation method and application thereof
10/20/2010CN101862456A Remedy
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862436A Chinese medicament for improving immunity of human bodies
10/20/2010CN101862432A Chinese medicament for treating urticaria
10/20/2010CN101862423A Preparation method for coix seed oil microemulsion
10/20/2010CN101862418A Rehabilitation capsule of drug-taking patient
10/20/2010CN101862415A Method for preparing nutritious liquor
10/20/2010CN101862372A Method for purifying flavones in mulberry leaves
10/20/2010CN101862371A Method for preparing flavone and alkaloid from mulberry leaves
10/20/2010CN101862369A Perilla and Rhodiola rosea capsules
10/20/2010CN101862366A Method for extracting medicament for treating allergic colitis from Alhagi sparsifolia plant and medicament and application thereof
10/20/2010CN101862362A Hydroxypropyl-beta-cyclodextrin inclusion compound of ginseng essential oil, preparation method and application
10/20/2010CN101862355A Medicine compound having function of promoting immunity
10/20/2010CN101862354A Pharmaceutical composition for adjusting immunity
10/20/2010CN101862342A External medicament for treating dermatophytosis
10/20/2010CN101862335A Medicine compound containing mycophenolate mofetil
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101862288A Biological facial washing milk prepared from pineapple, pawpaw, pomelo, moxa leaf and pearl
10/20/2010CN101862028A Wintergreen extraction method, cigarette comprising same and preparation method thereof
10/20/2010CN101165047B Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method
10/20/2010CN101066150B Sea-buckthorn nectar and its production process
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7816340 Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acid
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 1172